Neurogenic heterotopic ossification

Brooker AF, Bowerman JW, Robinson RA et al. Ectopic ossification following total hip replacement. Incidence and method of classification. J Bone Joint Surg Am 1973; 55(8): 1629–1632.

Garland DE. A clinical perspective on common forms of acquired heterotopic ossification. Clin Orthop 1991; (263): 13–29.

Pignolo RJ, Kaplan FS. Clinical staging of fibrodysplasia ossificans progressiva (FOP). Bone 2018; 109: 111–114. Dostupné z DOI: <http://dx.doi.org/10.1016/j.bone.2017.09.014>.

Kaplan FS, Craver R, MacEwen GD et al. Progressive osseous heteroplasia: a distinct developmental disorder of heterotopic ossification. Two new case reports and follow-up of three previously reported cases. J Bone Joint Surg Am 1994; 76(3): 425–36.

Cipriano CA, Pill SG, Keenan MA. Heterotopic ossification following traumatic brain injury and spinal cord injury. J Am Acad Orthop Surg 2009; 17(11): 689–697. Dostupné z DOI: <http://dx.doi.org/10.5435/00124635–200911000–00003>.

van Kuijk AA, Geurts AC, van Kuppevelt HJ. Neurogenic heterotopic ossification in spinal cord injury. Spinal Cord 2002; 40(7): 313–326. Dostupné z DOI: <http://10.1038/sj.sc.3101309>.

Vanden Bossche L, Vanderstraeten G. Heterotopic ossification: a review. J Rehabil Med 2005; 37(3): 129–136. <http://dx.doi.org/10.1080/16501970510027628>.

Genêt F, Jourdan C, Schnitzler A et al. Troublesome heterotopic ossification after central nervous system damage: a survey of 570 surgeries. PloS One 2011; 6(1): e16632. Dostupné z DOI: <http://dx.doi.org/10.1371/journal.pone.0016632>.

Halas RA, Karuppiah S. Heterotopic ossification of the hip after stroke. Curr Orthop Pract 2011; 22(2): E19–E21. Dostupné z DOI: <http://dx.doi.org/10.1097/BCO.0b013e3181ff73af>.

Simonsen LL, Sonne-Holm S, Krasheninnikoff M et al. Symptomatic heterotopic ossification after very severe traumatic brain injury in 114 patients: incidence and risk factors. Injury 2007; 38(10):1146–1150. Dostupné z DOI: <http://dx.doi.org/10.1016/j.injury.2007.03.019>.

Garland DE. Clinical observations on fractures and heterotopic ossification in the spinal cord and traumatic brain injured populations. Clin Orthop Relat Res 1988; (233): 86–101.

Ebinger T, Roesch M, Kiefer H et al. Influence of etiology in heterotopic bone formation of the hip. J Trauma 2000; 48(6): 1058–1062. Dostupné z DOI: <http://dx.doi.org/10.1097/00005373–200006000–00010>.

Garland DE, O’Hollaren RM. Fractures and dislocations about the elbow in the head-injured adult. Clin Orthop Relat Res 1982; (168): 38–41.

Wittenberg RH, Peschke U, Bötel U. Heterotopic ossification after spinal cord injury: Epidemiology and risk factors. J Bone Joint Surg Br 1992; 74(2): 215–218.

Scher AT. The incidence of ectopic bone formation in post-traumatic paraplegic patients of different racial groups. Paraplegia 1976; 14(3): 202–206. Dostupné z DOI: <http://dx.doi.org/10.1038/sc.1976.35>.

Sundaram NA, Murphy JC. Heterotopic bone formation following total hip arthroplasty in ankylosing spondylitis. Clin Orthop Relat Res 1986; (207): 223–226.

Larson JM, Michalski JP, Collacott EA et al. Increased prevalence of HLA-B27 in patients with ectopic ossification following traumatic spinal cord injury. Rheumatol Rehabil 1981; 20(4): 193–197. Dostupné z DOI: <http://dx.doi.org/10.1093/rheumatology/20.4.193>.

Garland DE, Alday B, Venos KG. Heterotopic ossification and HLA antigens. Arch Phys Med Rehabil 1984; 65(9): 531–532.

Mitchell EJ, Canter J, Norris P et al. The genetics of heterotopic ossification: insight into the bone remodeling pathway. J Orthop Trauma 2010; 24(9): 530–533. Dostupné z DOI: <http://dx.doi.org/10.1097/BOT.0b013e3181ed147b>.

Pape HC, Lehmann U, van Griensven M et al. Heterotopic ossifications in patients after severe blunt trauma with and without head trauma: incidence and patterns of distribution. J Orthop Trauma 2001; 15(4): 229–237. Dostupné z DOI: <http://dx.doi.org/10.1097/00005131–200105000–00001>.

Brighton CT, Schaffer JL, Shapiro DB et al. Proliferation and macromolecular synthesis by rat calvarial bone cells grown in various oxygen tensions. J Orthop Res 1991; 9(6): 847–854. Dostupné z DOI: <http://dx.doi.org/10.1002/jor.1100090610>.

Miller LF, O’Neill CJ. Myositis ossificans in paraplegics. J Bone Joint Surg 1949; 31(A): 283–294.

Rossier AB, Bussat P, Infante F et al. Current facts on para-osteo-arthropathy (POA). Paraplegia 1973; 11(1): 38–78. Dostupné z DOI: <http://dx.doi.org/10.1038/sc.1973.5>.

Jensen LL, Halar E, Little JW et al. Neurogenic heterotopic ossification. Am J Phys Med 1987; 66(6): 351–363.

Ackerman LV. Extra osseous localized non-neoplastic bone and cartilage formation. J Bone Joint Surg 1958; 40-A(2): 279–298.

Peck RJ, Metreweli C. Early myositis ossificans: a new echographic sign. Clin Radiol 1988; 39(6): 586–588. Dostupné z DOI: <http://dx.doi.org/10.1016/s0009–9260(88)80052–7>.

Chalmers J, Gray DH, Rush J. Observations on the induction of bone in soft tissues. J Bone Joint Surg 1975; 57(1): 36–45.

Cadosch D, Toffoli AM, Gautschi OP et al. Serum after traumatic brain injury increases proliferation and supports expression of osteoblast markers in muscle cells. J Bone Joint Surg Am 2010; 92(3): 645–653. Dostupné z DOI: <http://dx.doi.org/10.2106/JBJS.I.00097>.

Mastrogiacomo M, Derubeis AR, Cancedda R. Bone and cartilage formation by skeletal muscle derived cells. J Cell Physiol 2005; 204(2): 594–603. Dostupné z DOI: <http://dx.doi.org/10.1002/jcp.20325>.

Gautschi OP, Cadosch D, Frey SP et al. Serum-mediated osteogenic effect in traumatic brain-injured patients. ANZ J Surg 2009; 79(6): 449–455. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1445–2197.2008.04803.x>.

Castillo J, Rodríguez I. Biochemical changes and inflammatory response as markers for brain ischaemia: molecular markers of diagnostic utility and prognosis in human clinical practice. Cerebrovasc Dis 2004; 17(Suppl 1): 7–18. Dostupné z DOI: <http://dx.doi.org/10.1159/000074791>.

Trentz OA, Handschin AE, Bestmann L et al. Influence of brain injury on early posttraumatic bone metabolism. Crit Care Med 2005; 33(2): 399–406. Dostupné z DOI: <http://dx.doi.org/10.1097/01.ccm.0000152221.87477.21>.

Hohmann EL, Elde RP, Rysavy JA et al. Innervation of periosteum and bone by sympathetic vasoactive intestinal peptide-containing nerve fibers. Science 1986; 232(4752): 868–871. Dostupné z DOI: <http://dx.doi.org/10.1126/science.3518059>.

Jones KB, Mollano AV, Morcuende JA et al. Bone and brain: a review of neural, hormonal, and musculoskeletal connections. Iowa Orthop J 2004; 24: 123–132.

Argyropoulou MI, Kostandi E, Kosta P et al. Heterotopic ossification of the knee joint in intensive care unit patients: early diagnosis with magnetic resonance imaging. Crit Care 2006; 10(5): R152. Dostupné z DOI: <http://dx.doi.org/10.1186/cc5083>.

Takeda S, Elefteriou F, Levasseur R et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 2002; 111(3): 305–317. Dostupné z DOI: <http://dx.doi.org/10.1016/s0092–8674(02)01049–8>.

Gordeladze JO, Drevon CA, Syversen U et al. Leptin stimulates human osteoblastic formation, de novo collagen synthesis, and mineralization: impact on differentiation markers, apoptosis and osteoclastic signaling. J Cell Biochem 2002; 85(4): 825–836. Dostupné z DOI: <http://dx.doi.org/10.1002/jcb.10156>.

Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004; 22(4): 233–241. Dostupné z DOI: <http://dx.doi.org/10.1080/08977190412331279890>.

Kang Q, Sun MH, Cheng H et al. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 2004; 11(17): 1312–1320. Dostupné z DOI: <http://dx.doi.org/10.1038/sj.gt.3302298>.

Salisbury E, Rodenberg E, Sonnet C et al. Sensory nerve induced inflammation contributes to heterotopic ossification. J Cell Biochem 2011; 112(10): 2748–58. Dostupné z DOI: <http://dx.doi.org/10.1002/jcb.23225>.

Kan L, Kitterman JA, Procissi D et al. CNS demyelination in fibrodysplasia ossificans progressiva. J Neurol 2012; 259(12): 2644–2655. Dostupné z DOI: <http://dx.doi.org/10.1007/s00415–012–6563-x>

Shehab D, Elgazzar AH, Collier BD. Heterotopic ossification. J Nucl Med 2002; 43(3): 346–353.

Schurch B, Capaul M, Vallotton MB et al. Prostaglandin E2 measurements: their value in the early diagnosis of heterotopic ossification in spinal cord injury patients. Arch Phys Med Rehabil 1997; 78(7): 687–691. Dostupné z DOI: <http://dx.doi.org/10.1016/s0003–9993(97)90074–5>.

Orzel JA, Rudd TG. Heterotopic bone formation: clinical, laboratory, and imaging correlation. J Nucl Med 1985; 26(2): 125–32.

Pistarini C, Carlevati S, Contardi A et al. Use of ultrasonography methods in the diagnosis of neurogenic paraosteoarthropathy in spinal cord injury. Recenti Prog Med 1995; 86(12): 483–488.

Popken F, Konig DP, Tantow M et al. Possibility of sonographic early diagnosis of heterotopic ossification after total hip-replacement. Unfallchirurg 2003; 106(1): 28–31. Dostupné z DOI: <http://dx.doi.org/10.1007/s00113–002–0461–0>.

Svircev JN, Wallbom AS. False-negative triple-phase bone scans in spinal cord injury to detect clinically suspect heterotopic ossification: a case series. J Spinal Cord Med 2008; 31(2): 194–196. Dostupné z DOI: <http://dx.doi.org/10.1080/10790268.2008.11760711>.

Banovac K, Williams JM, Patrick LD et al. Prevention of heterotopic ossification after spinal cord injury with indomethacin. Spinal Cord 2001; 39(7): 370–374. <http://dx.doi.org/10.1038/sj.sc.3101166>.

Banovac K, Williams JM, Patrick LD et al. Prevention of heterotopic ossification after spinal cord injury with COX-2 selective inhibitor (rofecoxib). Spinal Cord 2004; 42(12): 707–710. Dostupné z DOI: <http://dx.doi.org/10.1038/sj.sc.3101628>.

Garland DE, Alday B, Venos KG et al. Diphosphonate treatment for heterotopic ossification in spinal cord injury patients. Clin Orthop 1983; (176): 197–200.

Spielman G, Gennarelli TA, Rogers CR. Disodium etidronate: its role in preventing heterotopic ossification in severe head injury. Arch Phys Med Rehabil 1983; 64(11): 539–542.

Banovac K. The effect of Etidronate on late development of heterotopic ossification after spinal cord injury. J Spinal Cord Med 2000; 23(1): 40–44. Dostupné z DOI: <http://dx.doi.org/10.1080/10790268.2000.11753507>.

Balboni TA, Gobezie R, Mamon HJ. Heterotopic ossification: pathophysiology, clinical features, and the role of radiotherapy for prophylaxis. Int J Radiat Oncol Biol Phys 2006; 65(5): 1289–1299. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ijrobp.2006.03.053>.

Seegenschmiedt MH, Keilholz L, Martus P et al. Prevention of heterotopic ossification about the hip: final results of two randomized trials in 410 patients using either preoperative or postoperative radiation therapy. Int J Radiat Oncol Biol Phys 1997; 39(1): 161–171. Dostupné z DOI: <http://dx.doi.org/10.1016/s0360–3016(97)00285-x>.

Sautter-Bihl ML, Hultenschmidt B, Liebermeister E et al. Fractionated and single-dose radiotherapy for heterotopic bone formation in patients with spinal cord injury. A phaseI/II study. Strahlenther Onkol 2001; 177(4): 200–205. Dostupné z DOI: <http://dx.doi.org/10.1007/pl00002399>.

Sautter-Bihl ML, Liebermeister E, Nanassy A. Radiotherapy as a local treatment option for heterotopic ossifications in patients with spinal cord injury. Spinal Cord 2000; 38(1): 33–36. Dostupné z DOI: <http://dx.doi.org/10.1038/sj.sc.3100847>.

Genet F, Jourdan C, Lautridou C et al. The impact of preoperative hip heterotopic ossification extent on recurrence in patients with head and spinal cord injury: a case control study. PLoS One 2011; 6(8): e23129. Dostupné z DOI: <http://dx.doi.org/10.1371/journal.pone.0023129>.

Denormandie P, de l’Escalopier N, Gatin L et al. Resection of neurogenic heterotopic ossification (NHO) of the hip. Orthop Traumatol Surg Res 2018; 104(1S): S121-S127. Dostupné z DOI: <http://dx.doi.org/10.1016/j.otsr.2017.04.015>.

Almangour W, Schnitzler A, Salga M et al. Recurrence of heterotopic ossification after removal in patients with traumatic brain injury: a systematic review. Ann Phys Rehabil Med 2016; 59(4): 263–269. Dostupné z DOI: <http://dx.doi.org/10.1016/j.rehab.2016.03.009>.